BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 15189690)

  • 1. [Expression of TSG-6 gene during 3T3-L1 preadipocyte differentiation and regulative role of tumor necrosis factor-alpha].
    Guo XR; Ding SL; Pan XQ; Gong HX; Fei L; Ni YH; Chen RH
    Zhonghua Er Ke Za Zhi; 2004 May; 42(5):344-7. PubMed ID: 15189690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of the NYGGF4 gene during human preadipocyte differentiation and the regulative role of tumor necrosis factor-alpha].
    Zhao Y; Wang J; Cai Y; Chen X; Zhang C; Guo X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):69-72. PubMed ID: 20140872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of ghrelin on the proliferation and differentiation of 3T3-L1 preadipocytes and its possible mechanisms].
    Liu J; Lin HH; Cheng PX; Hu XF; Lu HL
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):69-73. PubMed ID: 19149928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARgamma without effects on Pref-1 expression.
    Xing H; Northrop JP; Grove JR; Kilpatrick KE; Su JL; Ringold GM
    Endocrinology; 1997 Jul; 138(7):2776-83. PubMed ID: 9202217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.
    Zhang B; Berger J; Hu E; Szalkowski D; White-Carrington S; Spiegelman BM; Moller DE
    Mol Endocrinol; 1996 Nov; 10(11):1457-66. PubMed ID: 8923470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine attenuates TNF-alpha induced changes in secretion of interleukin-6, plasminogen activator inhibitor-1 and adiponectin from 3T3-L1 adipocytes.
    Araki S; Dobashi K; Kubo K; Yamamoto Y; Asayama K; Shirahata A
    Life Sci; 2006 Nov; 79(25):2405-12. PubMed ID: 16952378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of extracellular superoxide dismutase during adipose differentiation in 3T3-L1 cells.
    Adachi T; Toishi T; Wu H; Kamiya T; Hara H
    Redox Rep; 2009; 14(1):34-40. PubMed ID: 19161676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory.
    Ruan H; Hacohen N; Golub TR; Van Parijs L; Lodish HF
    Diabetes; 2002 May; 51(5):1319-36. PubMed ID: 11978627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of adrenomedullin and resistin in 3T3-L1 adipocytes treated with tumor necrosis factor-alpha.
    Li Y; Totsune K; Takeda K; Furuyama K; Shibahara S; Takahashi K
    Eur J Endocrinol; 2003 Sep; 149(3):231-8. PubMed ID: 12943526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells.
    Szalkowski D; White-Carrington S; Berger J; Zhang B
    Endocrinology; 1995 Apr; 136(4):1474-81. PubMed ID: 7895657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes.
    Kralisch S; Klein J; Lossner U; Bluher M; Paschke R; Stumvoll M; Fasshauer M
    J Endocrinol; 2005 Jun; 185(3):R1-8. PubMed ID: 15930160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes.
    Fasshauer M; Klein J; Lossner U; Paschke R
    Horm Metab Res; 2003 Mar; 35(3):147-52. PubMed ID: 12734774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of versican and hyaluronan in the differentiation of 3T3-L1 cells into preadipocytes and mature adipocytes.
    Zizola CF; Julianelli V; Bertolesi G; Yanagishita M; Calvo JC
    Matrix Biol; 2007 Jul; 26(6):419-30. PubMed ID: 17513099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated glucosamine inhibits adipogenesis in 3T3-L1 adipocytes.
    Kong CS; Kim JA; Eom TK; Kim SK
    J Nutr Biochem; 2010 May; 21(5):438-43. PubMed ID: 19427183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of iNOS and NO in TNF-alpha-downregulated resistin gene expression in 3T3-L1 adipocytes.
    Juan CC; Lien CC; Chang CL; Huang YH; Ho LT
    Obesity (Silver Spring); 2008 Jun; 16(6):1219-25. PubMed ID: 18369347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 is a positive regulator of tumor necrosis factor alpha-induced adipose-related protein in 3T3-L1 adipocytes.
    Fasshauer M; Kralisch S; Klier M; Lossner U; Bluher M; Chambaut-Guérin AM; Klein J; Paschke R
    FEBS Lett; 2004 Feb; 560(1-3):153-7. PubMed ID: 14988015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fatty acid regulation on visfatin gene expression in adipocytes.
    Wen Y; Wang HW; Wu J; Lu HL; Hu XF; Cianflone K
    Chin Med J (Engl); 2006 Oct; 119(20):1701-8. PubMed ID: 17097017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Carotene accumulation in 3T3-L1 adipocytes inhibits the elevation of reactive oxygen species and the suppression of genes related to insulin sensitivity induced by tumor necrosis factor-α.
    Kameji H; Mochizuki K; Miyoshi N; Goda T
    Nutrition; 2010; 26(11-12):1151-6. PubMed ID: 20097535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role and possible mechanism of lncRNA U90926 in modulating 3T3-L1 preadipocyte differentiation.
    Chen J; Liu Y; Lu S; Yin L; Zong C; Cui S; Qin D; Yang Y; Guan Q; Li X; Wang X
    Int J Obes (Lond); 2017 Feb; 41(2):299-308. PubMed ID: 27780975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.